Attributing the costs of health & social care Research & Development Understanding AcoRD

Size: px
Start display at page:

Download "Attributing the costs of health & social care Research & Development Understanding AcoRD"

Transcription

1 Attributing the costs of health & social care Research & Development Understanding AcoRD Trudi Simmons Senior Manager Research Finance & Programmes 1

2 Implementation Intoduction Basic principles behind the guidance The attribution process Common problems in attributing costs 2

3 Implementation AcoRD Published in May 2012 & adopted by England, Scotland, Wales & NI Published on the Gov at: 1. Working Group established to look at key issues around implementation 3

4 Principles of AcoRD Based on original principles set out in HSG(97)32 Uses the same three cost categories and definitions as HSG(97)32 Focuses on why an activity takes place rather than where or by whom Focuses on the Primary Purpose of an activity 4

5 Three sections Format of Guidance Main section that covers the background, principles and attribution process Annex A provides an Exemplar list of activities and where they should be attributed Annex B provides a set of Frequently Asked Questions (FAQs) updated regularly 5

6 Exemplar Lists Split into 3 sections Research, Support and Treatment Research Section has 2 parts Part A costs met by all grant funders Part B costs met by grant funders except where the funder is a member of the AMRC when DH will meet the cost. 6

7 The Categories of Costs Three types of costs: Research costs Treatment costs NHS Service Support Costs 7

8 Research Costs Costs of the R&D itself that end when the research ends. They relate to activities that are being undertaken to answer the research questions Met by grant funders through the award of a research grant except for PART B costs if funder is an AMRC member DH will meet PART B costs mainly via Research Capability funding (RCF) and Networks 8

9 Treatment Costs Patient care costs which would continue to be incurred if the patient care service in question continued to be provided after the R&D study had stopped 1. For the purposes of the attribution it should be assumed that an experimental intervention/ service being tested will continue after the end of the study Met through the normal commissioning process 9

10 Excess Treatment Costs (ETCs) ETCs are the difference between the cost of usual care and the cost of the treatment provided as part of the study Sometimes there are treatment savings rather than excess treatment costs 10

11 NHS Service Support Costs The additional patient care costs associated with the research, which would end once the R&D activity in question had stopped, even if the patient care involved continued to be provided Met from the R&D budget by the Health Departments of the United Kingdom 11

12 Attribution Process Concept of NHS patient care services and the premise that the NHS bears the cost of caring for its patients even when they are involved in a research study NHS patient care service is defined as a service provided by, or on behalf of, the NHS where that service treats, or contributes to, the care needs of a patient. 12

13 Two step approach step 1 Identify the core R&D activities the are being undertaken to answer the research question and which end when the research ends. These activities do not contribute to a NHS patient care service. These are Research Costs Examples of Research Costs are contained in Annex A 13

14 Step 2 NHS Patient Care Service Activities Activity that is part of NHS Services must be split between: NHS Treatment Costs NHS Support Costs 14

15 Treatment or Support Activity An activity is a NHS Treatment activity If it is integral to the provision of a treatment regime, whether this is standard or experimental An activity is a NHS Service Support activity if the patient care activity is primarily undertaken to facilitate research or is driven by the NHS duty of care to a patient, eg to ensure the safety of a patient participating in research 15

16 The attribution process Step 1 Step 2 In the context of this study is the activity a service provided by, or on behalf of, the NHS where that service treats or contributes to the care needs of a patient Yes No The activity is a patient care cost. Is the activity integral to the provision of a treatment (or diagnostic) regime? The activity is a Research Cost because it is not directly contributing to patient care Is the funder an AMRC member? Yes The activity is a Treatment Cost No The activity is a Service Support Cost Attribute Research activities between Part A and Part B 16

17 Treatment Costs As a rule of thumb most interventions that are being tested or compared as part of a study will be treatment costs even if they are experimental, unlicensed for the condition, not NICE approved, or there are no plans to continue with the intervention after the study has ended because the CCGs won t fund But placebo or sham treatments are research costs 17

18 Examples of NHS Support Activities The processing of the patient record to identify patients who may be suitable to approach to ask if they wish to participate in a research project; Obtaining informed consent; Additional investigations, assessments and tests where the results are required by the patient s care team to ensure patient safety and where arrangements are in place to feed the results back to the clinician 18

19 19 Common issues Attributing the costs of R&D is complex DH piloting an Activity Capture and Attribution Template (ACAT) to help No one size fits all Need to understand the detail of the study Why is the activity taking place? What usually happens to a patient? What would happen to the patient if they had the same treatment outside of a research study? Network support applies to research taking place in the NHS or in a NHS service provider Efficient study design can help to minimise cost Seek appropriate advice before grant submission

20 Common attribution mistakes Not referring back to the definitions of the 3 types of costs Attributing treatment costs as Support or Research costs Assuming because an activity takes place in the NHS it must be a NHS cost not true Assuming that funding for NHS Support and Treatment costs works in the same way as funding for research costs 20

21 21 NHS SSC Case Study Pam Gurney, University of Exeter Medical School

22 University of Exeter Medical School Case Study 1. Brief history of the School 2. Details on the funder 3. How we dealt with the difficult terms and conditions

23 Brief History of the University of Exeter Medical School 2002 took our first students as Peninsula Medical School (PMS) 2007 became the Peninsula College of Medicine and Dentistry (PCMD) 2013 split from Plymouth University and became the University of Exeter Medical School (UEMS)

24 Funder An AMRC Registered Charity As an AMRC registered charity, will not be required to pay (detailed in AcoRD Appendix A, Part B) are as follows: o Local study trial co-ordination and management. o Data collection needed to answer the questions that the research study is addressing (including collecting data for and completing the report). o Regulatory preparation and compliance including obtaining ethical approval and complying with the Medicine for Human Use (Clinical Trials) Regulations o The time taken by Chief and Principal Investigators (CI and PI) to explain the study to professional colleagues, and to understand, the research elements of a study. For example the time taken to explain the criteria for patient eligibility or to explain the randomisation protocol. o Sponsorship fees such as MHRA fees, and CTA annual renewal fees.

25 Our Solution United front with the academic / clinician One meeting the attendees being the academic, the HEI representative and the CRN representative Open discussion between all parties Contact with the CRN to make them aware of the cost commitment should the bid go ahead

26 Conclusion It is necessary, when dealing with SSC and ETCs that we work together with both the academic and the CRN to ensure that things are costed correctly. We understand the rules of each individual funder to ensure that we can attribute these costs appropriately.

Attributing the costs of health and social care Research & Development (AcoRD)

Attributing the costs of health and social care Research & Development (AcoRD) Frequently Asked Questions Annex B Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs, NHS Support Costs

More information

Attributing the costs of Health and Social Care Research & Development (AcoRD)

Attributing the costs of Health and Social Care Research & Development (AcoRD) HSC R&D Division Attributing the costs of Health and Social Care Research & Development (AcoRD) Contents Contents... 2 Purpose... 3 Background... 3 Basic Principles...4 Commercial Contract Studies...4-5

More information

Attributing the costs of health and social care Research and Development (AcoRD)

Attributing the costs of health and social care Research and Development (AcoRD) Frequently Asked Questions Annex B - Scotland Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs, NHS

More information

The people needed to complete the costs for a funding application are:

The people needed to complete the costs for a funding application are: Research Design Service London Guide to costing grant applications The people needed to complete the costs for a funding application are: The chief investigators and or senior researchers Your local Trust,

More information

Attributing the costs of health and social care Research and Development (AcoRD)

Attributing the costs of health and social care Research and Development (AcoRD) Attributing the costs of health and social care Research and Development (AcoRD) Page 1 of 8 Contents Contents. 2 Purpose.. 3 Background. 3 Basic Principles.. 4 Commercial Contract Studies.. 4 Non-commercial

More information

Research funding applications involving Cardiff & Vale UHB. Emma Lewis R&D Coordinator. Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a r Fro

Research funding applications involving Cardiff & Vale UHB. Emma Lewis R&D Coordinator. Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a r Fro Research funding applications involving Cardiff & Vale UHB Emma Lewis R&D Coordinator Objectives R&D review of grant applications Identifying resources required for your project Attributing costs using

More information

Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS?

Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? Annex B Frequently Asked Questions Updated May 2015 Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs,

More information

Attributing the costs of health and social care Research & Development (AcoRD)

Attributing the costs of health and social care Research & Development (AcoRD) Frequently Asked Questions Updated December 2015 Annex B Contents 1. Introduction... 2 2. Funding sources... 2 3. Clinical Research Network funding... 5 4. Application advice services/nhs permissions...

More information

Summary of the role and operation of NHS Research Management Offices in England

Summary of the role and operation of NHS Research Management Offices in England Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices

More information

An introduction to Research Management and Governance (RM&G) in the NHS

An introduction to Research Management and Governance (RM&G) in the NHS An introduction to Research Management and Governance (RM&G) in the NHS Rachel Davis Assistant RM&G Project Manager Natassia Embury R&D Facilitator 14/04/2014 Delivering clinical research to make patients,

More information

Study-wide considerations: identifies the areas of the criterion the lead reviewer should consider when conducting the review

Study-wide considerations: identifies the areas of the criterion the lead reviewer should consider when conducting the review UK STUDY-WIDE GOVERNANCE CRITERIA FOR R&D REVIEW INTRODUCTION The following document is intended to provide operational guidance to the person taking the UK lead in conducting the R&D Study-Wide review

More information

PROPOSED REVISED GUIDANCE TO NHS BOARDS FOR CONSULTATION

PROPOSED REVISED GUIDANCE TO NHS BOARDS FOR CONSULTATION Dear Colleague Arrangements for NHS Patients Receiving Private Healthcare 1. This letter provides revised guidance to NHS Boards covering situations where patients obtain private healthcare in addition

More information

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:

More information

CRN: South London Funding Model

CRN: South London Funding Model Summary of Partnership Group Agreement to Clinical Research Network: South London Funding Model Proposal 1. Introduction The Clinical Research Network: South London (CRN: South London) was formed in April

More information

Commissioning Policy: Implementation and funding of NICE guidance. April 2013. Reference : NHSCB/CP/05

Commissioning Policy: Implementation and funding of NICE guidance. April 2013. Reference : NHSCB/CP/05 Commissioning Policy: Implementation and funding of NICE guidance April 2013 Reference : NHSCB/CP/05 NHS Commissioning Board Commissioning Policy: Implementation and funding of guidance produced by the

More information

Managing Research in Hospices

Managing Research in Hospices Managing Research in Hospices Paul Perkins Consultant in Palliative Medicine Gloucestershire Hospitals NHS Foundation Trust and Sue Ryder Leckhampton Court Hospice Cheltenham Why? We need to know what

More information

Form PG4 Developmental Research Project Grant Guidance for Applicants

Form PG4 Developmental Research Project Grant Guidance for Applicants Form PG4 Developmental Research Project Grant Guidance for Applicants Research Department, Stroke Association, Stroke Association House, 240 City Road, London EC1V 2PR, Tel: 0207 566 1543 Email: research@stroke.org.uk

More information

TRIAL MASTER FILE- SPONSORED

TRIAL MASTER FILE- SPONSORED gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER

More information

National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)

National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CRN Website for the latest version. Version: 6.0 Status: Consultation in

More information

Does my project require review by a Research Ethics Committee?

Does my project require review by a Research Ethics Committee? National Research Ethics Service Does my project require review by a Research Ethics Committee? This algorithm is designed to assist researchers, sponsors and R&D offices in determining whether a project

More information

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare

More information

Archiving of Research Documentation

Archiving of Research Documentation Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment

More information

RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS. Research Governance Group

RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS. Research Governance Group RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS Reference No: UHB 074 Version No: 5 Previous Trust / LHB Ref No: N/A Documents to read alongside

More information

CLINICAL RESEARCH NETWORK

CLINICAL RESEARCH NETWORK CLINICAL RESEARCH NETWORK Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the

More information

By e-mail. To Attached List. 12 December 2008. Dear Colleague. Arrangements for NHS Patients Receiving Private Healthcare

By e-mail. To Attached List. 12 December 2008. Dear Colleague. Arrangements for NHS Patients Receiving Private Healthcare Healthcare Policy and Strategy Directorate Derek Feeley, Director T: 0131-244 1727 F: 0131-244 2042 E: derek.feeley@scotland.gsi.gov.uk By e-mail To Attached List 12 December 2008 Dear Colleague Arrangements

More information

Wales Patient Access Scheme: Process Guidance

Wales Patient Access Scheme: Process Guidance Wales Patient Access Scheme: Process Guidance July 2012 (Updated September 2014) This guidance document has been prepared by the Patient Access Scheme Wales Group, with support from the All Wales Therapeutics

More information

Commissioning Policy (EMSCGP005V2) Defining the boundaries between NHS and Private Healthcare

Commissioning Policy (EMSCGP005V2) Defining the boundaries between NHS and Private Healthcare Commissioning Policy (EMSCGP005V2) Defining the boundaries between NHS and Private Healthcare Although Primary Care Trusts (PCTs) and East Midlands Specialised Commissioning Group (EMSCG) were abolished

More information

Research is everybody s business

Research is everybody s business Research and Development Strategy (DRAFT) 2013-2018 Research is everybody s business 1 Information Reader Box to be inserted for documents six pages and over. (To be inserted in final version, after consultation

More information

Document Title: Research Database Application (ReDA)

Document Title: Research Database Application (ReDA) Document Title: Research Database Application (ReDA) Document Number: SOP035 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

gsop-32-02 - Vendor Assessment SOP page 1 of 10

gsop-32-02 - Vendor Assessment SOP page 1 of 10 gsop-32-02 - Vendor Assessment SOP page 1 of 10 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust VENDOR ASSESSMENT Research & Development

More information

Research Study Close-down and Archiving Procedures

Research Study Close-down and Archiving Procedures Title: Outcome Statement: Research Study Close-down and Archiving Procedures To inform researchers of the process for closing down research studies, retaining and storing research materials in the Trust.

More information

Uncontrolled When Printed. Version 1.1. Consultation Group: Approver: Co-ordinators: Grampian Medicines Management Group. Deputy Director of Pharmacy

Uncontrolled When Printed. Version 1.1. Consultation Group: Approver: Co-ordinators: Grampian Medicines Management Group. Deputy Director of Pharmacy NHS Grampian Staff Policy For Patients To Receive Aspects Of Their Treatment Through Private Healthcare Providers (Co-Payments) In Respect Of Medicines Co-ordinators: Deputy Director of Pharmacy Consultation

More information

STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders

STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders STANDARD OPERATING PROCEDURE FOR RESEARCH Management of Essential Documents and Trial Folders Author Linda Ward Author s Job Title QA Coordinator Division Department Version number 2 Ref SOP/CLN/001/2

More information

Research Governance Framework for Health and Social Care

Research Governance Framework for Health and Social Care Research Governance Framework for Health and Social Care Second edition, 2005 Research Governance Framework for Health and Social Care Foreword The Research Governance Framework outlines principles of

More information

Standard Operating Procedures (SOP) Research and Development Office

Standard Operating Procedures (SOP) Research and Development Office Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Undertaking Risk Assessment of a Research and Development Project SOP Number: 33 Version Number: 1.0 Supercedes: N/A Effective

More information

PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIALS DATA RECORD ADJUSTMENT PROCESS

PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIALS DATA RECORD ADJUSTMENT PROCESS PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIALS DATA RECORD ADJUSTMENT PROCESS Version Control Amended small error in Acronyms table (page 2) 1 Acronyms CTP FPR MHRA REC SOP TMB VRA Clinical

More information

The Practicalities of Data Standards

The Practicalities of Data Standards The Practicalities of Data Standards Provided by Catherine Carpenter-Clawson, Research Network Manager For EDGE User Conference 2014 17 th March 2014 Contents Example 1: Local challenges with study arm

More information

STANDARD OPERATING PROCEDURE. Risk Assessment of STH sponsored CTIMPs

STANDARD OPERATING PROCEDURE. Risk Assessment of STH sponsored CTIMPs Research Department STANDARD OPERATING PROCEDURE of STH sponsored CTIMPs SOP History None SOP Number C118 Created STH Research Department (EW) Reviewed STH Research Department (EW) Superseded Version 1.0,

More information

CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator

CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley

More information

Appendix 3 INDIVIDUAL PATIENT DRUG TREATMENT. POLICY AND PROCESS FOR DECISION MAKING September 2007

Appendix 3 INDIVIDUAL PATIENT DRUG TREATMENT. POLICY AND PROCESS FOR DECISION MAKING September 2007 Appendix 3 INDIVIDUAL PATIENT DRUG TREATMENT POLICY AND PROCESS FOR DECISION MAKING September 2007 Approved by Board: 6 th September 2007 Date Implemented: 1 st October 2007 Review Date: September 2008

More information

A Guide to Clinical Trials

A Guide to Clinical Trials A Guide to Clinical Trials For young people with cancer and their parents Children s Cancer and Leukaemia Group www.cclg.org.uk Original booklet produced in conjunction with the CCLG Patient Advocacy Committee.

More information

COMMERCIAL SPONSORSHIP ETHICAL STANDARDS FOR THE NHS

COMMERCIAL SPONSORSHIP ETHICAL STANDARDS FOR THE NHS November 2000 DEPT OF HEALTH LOGO COMMERCIAL SPONSORSHIP ETHICAL STANDARDS FOR THE NHS Contact point and queries Any queries on this document should, in the first instance, be directed to the Regional

More information

GP Patient Survey Your doctor, your experience, your say

GP Patient Survey Your doctor, your experience, your say GP Patient Survey Your doctor, your experience, your say Guidance 2007/08 for strategic health authorities, primary care trusts and GP practices Introduction 1. This document provides guidance on this

More information

Guidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1)

Guidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1) Guidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1) What is the HRA Statement of Activities? The Statement of Activities is part of the application

More information

RESEARCH GOVERNANCE POLICY

RESEARCH GOVERNANCE POLICY RESEARCH GOVERNANCE POLICY Policy Title Version: Approved by: Date of approval: 29 June 2015 Policy supersedes: Lead Board Director: Policy Lead (and author if different): Name of responsible committee/group:

More information

European cross border healthcare: Information for commissioners

European cross border healthcare: Information for commissioners European cross border healthcare: Information for commissioners Published: June 2014 1 2 European Cross Border Healthcare Information for Commissioners First published: July 2013 Updated: June 2014 3 Contents

More information

NHS Chartutes - A Guide to the governing Body

NHS Chartutes - A Guide to the governing Body Constitutional Changes Proposed by Legal Advisers At Clause 4.1.2, changed the term Board to Governing Body to align with the term used in the legislation. Page 14. Amended Clause 4.8.1 to clarify the

More information

Research governance policy

Research governance policy Research governance policy Responsible Officer Author Ben Bennett, Business Planning & Resources Director Sarah Garner, Associate Director, Science Policy & Research Programme Date effective from July

More information

Consultancy spending approval process: Initial guidance to NHS foundation trusts

Consultancy spending approval process: Initial guidance to NHS foundation trusts Annex One Consultancy spending approval process: Initial guidance to NHS foundation trusts Summary 1. Monitor, the NHS Trust Development Authority (TDA) and NHS England are jointly implementing an approval

More information

OVERVIEW OF IPTR AND NON-FORMULARY PROCESS IN THE ACUTE SECTOR

OVERVIEW OF IPTR AND NON-FORMULARY PROCESS IN THE ACUTE SECTOR 5.2: POLICY FOR THE MANAGEMENT OF INDIVIDUAL PATIENT TREATMENT REQUESTS IMPORTANT NOTE: This policy document is subject to review pending the introduction of the Peer Approval Clinical System which will

More information

MRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council

MRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council MRC Clinical Trials Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 Medical Research Council MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 MRC GUIDELINES FOR

More information

Research Governance Framework for Health and Social Care in Wales Second Edition

Research Governance Framework for Health and Social Care in Wales Second Edition Research Governance Framework for Health and Social Care in Wales Second Edition Contents Foreword 1 1. Purpose and Scope 3 2. Standards 7 2.1 Introduction 7 2.2 Ethics 8 2.3 Science 13 2.4 Information

More information

EX GRATIA PROVISION OF XYREM TO PANDEMRIX AND NARCOLEPSY PERSONAL INJURY CLAIMANTS BY THE DEPARTMENT OF HEALTH

EX GRATIA PROVISION OF XYREM TO PANDEMRIX AND NARCOLEPSY PERSONAL INJURY CLAIMANTS BY THE DEPARTMENT OF HEALTH EX GRATIA PROVISION OF XYREM TO PANDEMRIX AND NARCOLEPSY PERSONAL INJURY CLAIMANTS BY THE DEPARTMENT OF HEALTH Introduction 1. This note describes the Department of Health s (DH) ex gratia and time-limited

More information

Responding to the NHS Constitution

Responding to the NHS Constitution December 2012 Developing the AMRC response to the consultation on the NHS Constitution The government is updating the NHS Constitution so that it will better reflect the legal rights and responsibilities

More information

Sutton & Merton Clinical Commissioning Groups Charitable Funds Grant Application Form. Background, Policy and Criteria for the award of grants

Sutton & Merton Clinical Commissioning Groups Charitable Funds Grant Application Form. Background, Policy and Criteria for the award of grants Sutton & Merton Clinical Commissioning Groups Charitable Funds Grant Application Form Background, Policy and Criteria for the award of grants Sutton and Merton Clinical Commissioning Groups Charitable

More information

Research in the NHS HR Good Practice Resource Pack

Research in the NHS HR Good Practice Resource Pack Research in the NHS HR Good Practice Resource Pack Acknowledgements The Research Passport system was first developed in Greater Manchester by a partnership of NHS organisations and the University of Manchester.

More information

Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010

Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010 Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices Response from Cancer Research UK to the Commission August 2010 1. Cancer Research UK (CR-UK) 1 is leading the world in finding

More information

GP Patient Survey Your Doctor, Your Experience, Your Say

GP Patient Survey Your Doctor, Your Experience, Your Say To: GP Practices Chief Executives of Primary Care Trusts Dear Colleague GP Patient Survey Your Doctor, Your Experience, Your Say This letter confirms arrangements for delivery of the 2008 GP Patient Survey.

More information

In April 2010, changes to both the GMS and PMS regulations came into force which:

In April 2010, changes to both the GMS and PMS regulations came into force which: GPC GUIDANCE: USE OF 084 NUMBERS BY GP PRACTICES Revised June 2012 (first edition published July 2011) Introduction A number of GP practices use telephone systems with non-geographical numbers, such as

More information

Section 5 onwards provides information aimed at researchers who are interested in working with us.

Section 5 onwards provides information aimed at researchers who are interested in working with us. NORWICH CLINICAL TRIALS UNIT This document provides an overview of the Norwich Clinical Trials Unit: Sections 1 to 3 describe the Norwich Clinical Trials Unit remit and structure for our stakeholders and

More information

DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004

DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Page 1 of 17 TABLE OF CONTENTS INTRODUCTION 4 EXECUTIVE SUMMARY 4 PUBLIC HEALTH BENEFITS 5 Good clinical practice 5 Good manufacturing

More information

ANNEX 11: ASSET MANAGEMENT POLICY

ANNEX 11: ASSET MANAGEMENT POLICY ANNEX 11: ASSET MANAGEMENT POLICY Electricity North West Limited Registered Office: 304 Bridgewater Place, Birchwood Park, Warrington, Cheshire. WA3 6XG. Registered no: 2366949 (England) Electricity North

More information

A Guide to Pharmacy Documentation For Clinical Trials

A Guide to Pharmacy Documentation For Clinical Trials A Guide to Pharmacy Documentation For Clinical Trials Roy Sinclair Clinical Trials Pharmacist St. George s Hospital (to Sep 2007) Lecturer Kingston University January 2008 A Guide to Pharmacy Documentation

More information

Implementing the Research Governance Framework Guidelines for New Researchers. Juliet MacArthur Alison Goulbourne

Implementing the Research Governance Framework Guidelines for New Researchers. Juliet MacArthur Alison Goulbourne Implementing the Research Governance Framework Guidelines for New Researchers Juliet MacArthur Alison Goulbourne March 2007 0 Note from the authors This document is designed to provide a step by step guide

More information

Responsibilities for meeting Patient Care Costs associated with Research and Development in the NHS

Responsibilities for meeting Patient Care Costs associated with Research and Development in the NHS Health Service Guidelines - ExEcut#m HsG(97)32 29 May 1997 Responsibilities for meeting Patient Care Costs associated with Research and Development in the NHS Executive summary Part J - General Responsibilities

More information

Legal and governance framework

Legal and governance framework Annex A Legal and governance framework This annex is a brief guide to the legal and governance framework relevant to research in the UK. It is not intended to be a comprehensive statement of the law or

More information

Preparing an effective bid

Preparing an effective bid Vascular Risk Assessment (Vascular Checks) - a new Local Enhanced Service Part 2 Preparing an effective bid Version 1.1 Guidance prepared by PSNC to support Local Pharmaceutical Committees About this guidance

More information

Trust/Host Site Approval. Presented by: Anika Kadchha Research Governance Officer

Trust/Host Site Approval. Presented by: Anika Kadchha Research Governance Officer Trust/Host Site Approval Presented by: Anika Kadchha Research Governance Officer Joint Research & Enterprise Office Training 19 th January Outline What is Research NHS Ethics (if required) Host Site Approval

More information

Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6

Introduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6 Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication

More information

Document Title: Supply of Clinical Trials Investigational Material: Dispensing, Returns and Accountability

Document Title: Supply of Clinical Trials Investigational Material: Dispensing, Returns and Accountability Document Title: Supply of Clinical Trials Investigational Material: Document Number: SOP072 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G

More information

Process for advising on the feasibility of implementing a patient access scheme

Process for advising on the feasibility of implementing a patient access scheme Process for advising on the feasibility of implementing a patient access scheme INTERIM September 2009 Patient Access Schemes Liaison Unit at NICE P001_PASLU_Process_Guide_V1.3 Page 1 of 21 Contents (to

More information

Specialty Selection Test (SST) Pilot INFORMATION PACK

Specialty Selection Test (SST) Pilot INFORMATION PACK Specialty Selection Test (SST) Pilot INFORMATION PACK Page 1 of 18 Contents Section 1: Introduction... 2 Section 2: One-page overview... 2 Section 3: FAQs for Applicants... 3 Section 2: FAQs for LETBs/Deaneries/Specialties...

More information

Chemicals and Life Sciences Industry Practice. Insurance and compensation in the event of injury in Phase I clinical trials in the United Kingdom

Chemicals and Life Sciences Industry Practice. Insurance and compensation in the event of injury in Phase I clinical trials in the United Kingdom Chemicals and Life Sciences Industry Practice Insurance and compensation in the event of injury in Phase I clinical trials in the United Kingdom i Insurance and compensation in the event of injury in Phase

More information

Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL

Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,

More information

Policy Research Programme Summary Final Report Form

Policy Research Programme Summary Final Report Form Policy Research Programme Summary Final Report Form 1. Project Details Project Title: Project Duration: (months) Evaluation of the costs and benefits of computerised on-scene decision support for ambulance

More information

PUBLIC HEALTH WALES NHS TRUST CHIEF EXECUTIVE JOB DESCRIPTION

PUBLIC HEALTH WALES NHS TRUST CHIEF EXECUTIVE JOB DESCRIPTION PUBLIC HEALTH WALES NHS TRUST CHIEF EXECUTIVE JOB DESCRIPTION Post Title: Accountable to: Chief Executive and Accountable Officer for Public Health Wales NHS Trust Trust Chairman and Board for the management

More information

PUBLIC HEALTH LIMITED OPEN CALL SCHEME (LOCS) PHA202 RESEARCH BRIEFING

PUBLIC HEALTH LIMITED OPEN CALL SCHEME (LOCS) PHA202 RESEARCH BRIEFING Introduction PUBLIC HEALTH LIMITED OPEN CALL SCHEME (LOCS) PHA202 RESEARCH BRIEFING Following publication of its new national health research strategy Best Research for Best Health (DH 2006a), the Department

More information

INFORMATION GOVERNANCE REVIEW EVIDENCE GATHERING: COMMISSIONING

INFORMATION GOVERNANCE REVIEW EVIDENCE GATHERING: COMMISSIONING INFORMATION GOVERNANCE REVIEW EVIDENCE GATHERING: COMMISSIONING Introduction In producing these questions, the Information Governance Review Panel has reviewed the legal and statutory basis for the processing

More information

Informatics: The future. An organisational summary

Informatics: The future. An organisational summary Informatics: The future An organisational summary DH INFORMATION READER BOX Policy HR/Workforce Management Planning/Performance Clinical Document Purpose Commissioner Development Provider Development Improvement

More information

NORWICH CLINICAL TRIALS UNIT OVERVIEW

NORWICH CLINICAL TRIALS UNIT OVERVIEW NORWICH CLINICAL TRIALS UNIT OVERVIEW This document provides an overview of the Norwich Clinical Trials Unit. Sections 1 to 3 describe the Norwich Clinical Trials Unit remit and structure. Section 4 gives

More information

Appropriate staffing in health and care settings

Appropriate staffing in health and care settings NMC Briefing Appropriate staffing in health and care settings What is the NMC s interest in staffing? The importance of appropriate staffing was reinforced by the Francis Reports into failings at Mid Staffordshire

More information

Information Governance Strategy. Version No 2.0

Information Governance Strategy. Version No 2.0 Plymouth Community Healthcare CIC Information Governance Strategy Version No 2.0 Notice to staff using a paper copy of this guidance. The policies and procedures page of PCH Intranet holds the most recent

More information

NHS North Durham Clinical Commissioning Group. Information Governance Strategy 2015/16

NHS North Durham Clinical Commissioning Group. Information Governance Strategy 2015/16 NHS North Durham Clinical Commissioning Group Information Governance Strategy 2015/16 Document Status Equality Impact Assessment Document Ratified/Approved By Final No impact Risk and Audit Committee/Governing

More information

Guidance on nominating a consultee for research involving adults who lack capacity to consent

Guidance on nominating a consultee for research involving adults who lack capacity to consent Guidance on nominating a consultee for research involving adults who lack capacity to consent Issued by the Secretary of State and the Welsh Ministers in accordance with section 32(3) of the Mental Capacity

More information

IHEEM WORKING WITH YOU TO DEVELOP YOUR CAREER

IHEEM WORKING WITH YOU TO DEVELOP YOUR CAREER TO DEVELOP www.iheem.org.uk Joint letter by President and CEO Joint letter by President and CEO Shaping the healthcare engineering and estate management landscape The Institute of Healthcare Engineering

More information

1 Introduction... 1. 2 History... 2. 3 Employing authority/trust indemnity: who is covered for what?... 3

1 Introduction... 1. 2 History... 2. 3 Employing authority/trust indemnity: who is covered for what?... 3 This guidance note describes the NHS indemnity scheme introduced in January 1990 and alerts members to its limitations. Members are advised to retain defence body membership or take out personal indemnity

More information

Information Governance Policy

Information Governance Policy Information Governance Policy Version: 4 Bodies consulted: Caldicott Guardian, IM&T Directors Approved by: MT Date Approved: 27/10/2015 Lead Manager: Governance Manager Responsible Director: SIRO Date

More information

The anatomy of a grant proposal

The anatomy of a grant proposal The anatomy of a grant proposal 1 st October 2015 / Lucy Parker, MaryCate MacLennan, Steff Hazlehurst Excellence in specialist and community healthcare The anatomy of a grant proposal 1st October 2015

More information

This document explains the main differences between two sets of performance metrics:

This document explains the main differences between two sets of performance metrics: Document Version 2.0 Date November 2013 The (70 day benchmark) and the NIHR Clinical Research Network High Level Objectives: a description of purpose, definition and differences Introduction This document

More information

Specification Document (11/1023)

Specification Document (11/1023) Responsive funding in the NIHR SDO programme: open call (with special interest in studies with an economic/costing component) Closing date 1.00pm on 15 September 2011 1. Introduction This is the fifth

More information

Evaluating the ENAT : reconciling findings from a mixed methods study

Evaluating the ENAT : reconciling findings from a mixed methods study School of Healthcare FACULTY OF MEDICINE AND HEALTH Evaluating the ENAT : reconciling findings from a mixed methods study Professor Claire A Hale School of Healthcare University of Leeds On behalf of the

More information

Medical Device Alert. Device Peristeen anal irrigation system manufactured by Coloplast Limited. Action by

Medical Device Alert. Device Peristeen anal irrigation system manufactured by Coloplast Limited. Action by Medical Device Alert Issued: 26 February 2014 at 16:00 Device Peristeen anal irrigation system manufactured by Coloplast Limited. Problem Risk of using transanal irrigation inappropriately. The manufacturer

More information

2.1 The NIHR Faculty Version 7 (July 2015) THE NIHR FACULTY

2.1 The NIHR Faculty Version 7 (July 2015) THE NIHR FACULTY THE NIHR FACULTY Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the NIHR Faculty

More information

The Research Design Service Yorkshire and the Humber CONTENTS TOP TIPS FOR QUALITATIVE RESEARCH TOP TIPS FOR QUANTITATIVE PROPOSALS

The Research Design Service Yorkshire and the Humber CONTENTS TOP TIPS FOR QUALITATIVE RESEARCH TOP TIPS FOR QUANTITATIVE PROPOSALS The Research Design Service Yorkshire and the Humber CONTENTS TOP TIPS FOR QUALITATIVE RESEARCH TOP TIPS FOR QUANTITATIVE PROPOSALS TOP TIPS FOR SYSTEMATIC REVIEWS TOP TIPS FOR ECONOMIC EVALUATION TOP

More information

New medicines in Scotland

New medicines in Scotland NHS SCOTLAND New medicines in Scotland who decides what the NHS can provide? What is this factsheet about? This factsheet explains the process that medicines go through before NHS doctors in Scotland can

More information

We are the nursing and midwifery regulator for England, Wales, Scotland, Northern Ireland and the Islands.

We are the nursing and midwifery regulator for England, Wales, Scotland, Northern Ireland and the Islands. The Prep handbook We are the nursing and midwifery regulator for England, Wales, Scotland, Northern Ireland and the Islands. We exist to safeguard the health and wellbeing of the public. We set standards

More information

WHAT ARE THE SPECIFIC DIFFERENCES BETWEEN VERSION 5.5 AND VERSION 5.6 OF THE RESEARCH ETHICS COMMITTEE STANDARD APPLICATION FORM?

WHAT ARE THE SPECIFIC DIFFERENCES BETWEEN VERSION 5.5 AND VERSION 5.6 OF THE RESEARCH ETHICS COMMITTEE STANDARD APPLICATION FORM? Application Form Cover Sheet - Addition of Application Version No. in Version 5.6 - Addition of Application Date in Version 5.6 - Remove Principal Investigator (deletion) - Remove Applicant s Signature

More information

Managing Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey

Managing Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Managing Risk in Clinical Research Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Aim of the session To explore the risks associated with clinical research and understand how

More information

Information for members

Information for members Information for members I-04-63 Suggested distribution Vice-Chancellors and Principals, Pro Vice- Chancellors (Research), University Registrars and Secretaries, Directors of Human Resources, Deans/Heads

More information

Systematic Reviews. knowledge to support evidence-informed health and social care

Systematic Reviews. knowledge to support evidence-informed health and social care Systematic Reviews knowledge to support evidence-informed health and social care By removing uncertainties in science and research, systematic reviews ensure that only the most effective and best-value

More information